Unknown PHASE4 INTERVENTIONAL 1-arm NCT04524897

The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children

Sponsor: Assiut University

Interventions Triamcinolone Injection in treatment of refractory benign Esophageal Stricture in children

Updated 6 times since 2020 Last updated: Oct 25, 2020 Started: Dec 1, 2020 Primary completion: Oct 31, 2021 Completion: Mar 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Esophageal Stricture and is currently ongoing. Assiut University leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Not Yet Recruiting PHASE4
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Sep 2020 — Nov 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.